Literature DB >> 9230473

Computational study of the conformational domains of peptide T.

M Filizola1, N B Centeno, J J Perez.   

Abstract

The conformational preferences of peptide T (ASTTTNYT) were analysed by means of computational methods. A thorough exploration of the conformational space was carried out within the framework of the molecular mechanics approach, using simulated annealing as a searching strategy. Specifically, in order to obtain a subset of low-energy conformations with energies close to the global minimum as complete as possible, a simulated annealing protocol was repeated several times in a recursive fashion. The results of the search indicate that the peptide exhibits a alpha-helical character although most of the conformations characterized, including the global minimum, can be described as bent conformations. Conformations exhibiting beta-turn motives previously proposed from NMR studies were also characterized, although they are not very predominant in the set of low-energy conformations.

Mesh:

Substances:

Year:  1997        PMID: 9230473     DOI: 10.1002/(SICI)1099-1387(199703)3:2%3C85::AID-PSC84%3E3.0.CO;2-0

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  3 in total

1.  A proposed bioactive conformation of peptide T.

Authors:  N B Centeno; J J Perez
Journal:  J Comput Aided Mol Des       Date:  1998-01       Impact factor: 3.686

2.  Proposed Bioactive Conformations of Opiorphin, an Endogenous Dual APN/NEP Inhibitor.

Authors:  Marta Pinto; Catherine Rougeot; Luis Gracia; Mònica Rosa; Andrés García; Gemma Arsequell; Gregorio Valencia; Nuria B Centeno
Journal:  ACS Med Chem Lett       Date:  2011-11-17       Impact factor: 4.345

3.  Topical application of an amygdalin analogue reduces inflammation and keratinocyte proliferation in a psoriasis mouse model.

Authors:  Nuria Gago-López; Carmen Lagunas Arnal; Juan J Perez; Erwin F Wagner
Journal:  Exp Dermatol       Date:  2021-05-28       Impact factor: 3.960

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.